Apollo Hospitals

Chennai, India Founded: 1983 • Age: 43 yrs Listed Fortune India 500 · #129 India's Most Valuable
Chain of multispecialty hospitals
Request Access
Report Incorrect Data
Page last updated

About Apollo Hospitals

Apollo Hospitals is a publicly listed company based in Chennai (India) founded in 1983 by Prathap C Reddy. Chain of multispecialty hospitals. The company has 1,426 employees. Apollo Hospitals has completed 4 acquisitions, including AyurVAID Hospitals, Hetero Pharmacy and Nova Specialty Hospitals. Its chief executive, as recorded, is Shivakumar Pattabhiraman. Its website apollohospitals.com draws about 5.5 million monthly visits. Its Indian entity Apollo Hospitals Enterprise Limited reported revenue of ₹25,465 Cr. Apollo Hospitals offers products and services including Cardiac Sciences, Oncology Services, and Neurosciences. Its focus areas include Hospital Chains, Multispecialty Hospital Chains and Health Systems. Its competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed competitors have raised funding.

Company details

Apollo Hospitals was founded in 1983 in Chennai, India, within the healthcare sector. A network of multispecialty hospitals is managed across the country, where services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, transplants, nephrology, urology, pulmonology, endocrinology, rheumatology, dermatology, and pediatrics are provided. Emphasis is placed on disease prevention and healthy lifestyles through educational programs and community efforts.

Apollo Hospitals is ranked #129 on the Fortune India 500 (2025).

Recognitions & Rankings of Apollo Hospitals

Fortune India 500 2025 edition
Rank#129
Total income
₹22,028 Cr
Profit
₹1,446 Cr
Last year #128
India's Most Valuable Companies 2025 edition · Source: Hurun India
Valuation
₹1,09,810 Cr
2024 #64 2023 #61 2022 #61
  • Headquarters Chennai, India
  • Employees 1,426
  • Founders Prathap C Reddy
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Medicine
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website apollohospitals.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Apollo Hospitals Enterprise Limited
Operational Areas
Healthcare → Hospitals & Clinical Care
Key Metrics
  • Market Cap
    ₹1,20,362 Cr

    APOLLOHOSP · NSE

  • Share Price
    ₹8,446.00

    +0.90% today

  • Revenue
    ₹25,228 Cr

    FY 2025-26 · +15.8% YoY

  • EBITDA
    ₹3,750 Cr

    Margin 14.9%

  • Net Profit
    ₹1,869 Cr

    FY 2025-26 · +37.8% YoY

  • P/E (TTM)
    58.8x

    P/B 13.0x

  • ROE
    22.6%

    ROCE 18.1%

  • Debt / Equity
    0.69

    Interest cover 15.6x

  • Latest Funding Round
    $160M (USD), Post-IPO

    Jan 2021

  • Investors
    KKR

    & 4 more

  • Employee Count
    1,426
  • Investments & Acquisitions
    AyurVAID Hospitals

    & 3 more

Products & Services of Apollo Hospitals

Apollo Hospitals offers a comprehensive portfolio of products and services, including Cardiac Sciences, Oncology Services, and Neurosciences.

Cardiac Sciences
Medical Specialty

Provides advanced heart care and surgical treatments for patients.

Oncology Services
Medical Specialty

Offers cancer diagnosis and treatment options for various conditions.

Neurosciences
Medical Specialty

Delivers care for brain and nerve disorders through expert interventions.

Apps and channels of Apollo Hospitals

its YouTube channel Apollo Hospitals has 48.4K subscribers and 30 videos.

Apollo Hospitals
YouTube 48.4K subscribers 30 videos Science & Technology
Open channel

Videos from Apollo Hospitals

The most watched videos on Apollo Hospitals's YouTube channel, Apollo Hospitals (48.4K subscribers). Click a video to play it here.

Healing Without Scars – How Robotic Cardiac Surgery is Rewriting the Future of Heart Care
78.4K views
Episode #2 | Voices in Care with Dr. Madhu Sasidhar featuring Dr. Rakesh Jalali
59.9K views
The future of health checks is here. 🚀 #ApolloProHealth #ApolloHospitals
602 views
Dr. Prathap C. Reddy, Founder & Chairman, Apollo Hospitals
521 views

More on Apollo Hospitals.

Funding Insights of Apollo Hospitals

  • Total Rounds 6
  • Last Round Post-IPO — $160M
  • First Round $7.5M

    (May 2005)

  • Investors Count 5

All 6 funding rounds of Apollo Hospitals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$160MPost-IPO––
–
Dec 2016$65.8MPost-IPO––
IFC Asset Management Company
Jan 2015$15MPost-IPO––
Sanofi
Oct 2013$89MPost-IPO––
KKR
Aug 2007$112.32MPost-IPO––
Apax
May 2005$7.5MPost-IPO––
One Equity Partners
Valuation history

5 investors in total: 5 institutional.

Investors in Apollo Hospitals

Apollo Hospitals has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Sanofi and One Equity Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
IFC Asset Management Company
Capital is mobilized and invested in sustainable emerging market companies.
ifcamc.orgWashington, Dc, United States
KKR
Multiple sectors are invested in by this private equity firm.
1976kkr.comNew York, United States
Apax Partners
Equity investments are focused on tech, services, and consumer sectors.
1981apax.comHong Kong, China
One Equity Partners
Private equity investments are made in North America and Europe.
2001oneequity.comNew York, United States
Sanofi
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas.
1973sanofi.comParis, France
Premium access

Investor details for Apollo Hospitals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Apollo Hospitals Enterprise Limited (Apollo Hospitals)

Apollo Hospitals Enterprise Limited is the primary company behind Apollo Hospitals. The boards of the 6 registered companies of Apollo Hospitals currently have 36 directors; the longest-serving is Pratap Chandra Reddy, appointed in 1988. 121 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pratap Chandra Reddy
DIN 00003654
Director16 Mar 198838 yrs 7 moIndraprastha Medical Corporation Limited, Apollo Hospitals Enterprise Limited
Preetha Reddy
DIN 00001871
Whole-time director03 Feb 199333 yrs 9 moApollo Hospitals Enterprise Limited
Suneeta Reddy
DIN 00001873
Director31 Aug 200521 yrs 2 moIndraprastha Medical Corporation Limited, Apollo Hospitals Enterprise Limited
Upasana Konidela
DIN 02781278
Director26 Aug 200917 yrs 2 moHealthnet Global Limited
Ashok Bajpai
DIN 06768096
Whole-time director21 Dec 201312 yrs 10 moApollo Rajshree Hospitals Private Limited
Akhileswaran Krishnan
DIN 05299539
Nominee Director21 Dec 201312 yrs 10 moApollo Rajshree Hospitals Private Limited
Shobana Kamineni
DIN 00003836
Director02 Jul 201412 yrs 4 moApollo Hospitals Enterprise Limited
Anindith Reddy Konda
DIN 06893398
Whole-time director01 Aug 201412 yrs 3 moHealthnet Global Limited
Vineeta Rai
DIN 07013113
Director07 Nov 201412 yrsIndraprastha Medical Corporation Limited
Rajasekaran Krishnakumar
DIN 03331512
Director12 Mar 201610 yrs 7 moAssam Hospitals Limited
Sidharth Bhargava
DIN 01777924
Whole-time director13 May 20179 yrs 5 moApollo Rajshree Hospitals Private Limited
Kannabiran Ravichandran
DIN 07975161
Director23 Dec 20178 yrs 10 moAssam Hospitals Limited, Apollo Rajshree Hospitals Private Limited
Ganesan Venkatraman
DIN 00010063
Director28 Mar 20188 yrs 7 moAssam Hospitals Limited, Apollo Rajshree Hospitals Private Limited
Pudugramam Murali Doraiswamy
DIN 08235560
Director27 Sep 20188 yrs 1 moApollo Hospitals Enterprise Limited
Velagapudi Kavitha Dutt
DIN 00139274
Director09 Feb 20197 yrs 8 moApollo Hospitals Enterprise Limited
Bhaskara Mandavilli Nageswara Rao
DIN 00287260
Director09 Feb 20197 yrs 8 moApollo Hospitals Enterprise Limited
Madhumita Ganguli
DIN 00676830
Director26 Jul 20197 yrs 3 moIndraprastha Medical Corporation Limited
Shivakumar Pattabhiraman
DIN 08570283
Managing Director05 Nov 20197 yrsIndraprastha Medical Corporation Limited, Apollo Rajshree Hospitals Private Limited
Shivram Sethuraman
DIN 07946245
Director10 Feb 20206 yrs 8 moApollo Rajshree Hospitals Private Limited
Karthik Anand Reddy
DIN 02354216
Designated Partner22 May 20206 yrs 5 moNeocardio Diagnostics Llp
Sankaranarayanan Muthu Krishnan
DIN 02573490
Designated Partner22 May 20206 yrs 5 moNeocardio Diagnostics Llp
Adarsh Jalan
DIN 00383250
Partner22 May 20206 yrs 5 moNeocardio Diagnostics Llp
Konda Sangita Reddy
DIN 00006285
Director24 Aug 20206 yrs 2 moIndraprastha Medical Corporation Limited, Healthnet Global Limited, Apollo Hospitals Enterprise Limited
Mahesh Verma
DIN 08997324
Director08 Feb 20215 yrs 8 moIndraprastha Medical Corporation Limited
Salil Singhal
DIN 00006629
Director08 Feb 20215 yrs 8 moIndraprastha Medical Corporation Limited
Som Mittal
DIN 00074842
Director21 Jul 20215 yrs 3 moApollo Hospitals Enterprise Limited
Tonmoy Das
DIN 00406958
Director09 Nov 20214 yrs 11 moAssam Hospitals Limited
Rama Bijapurkar
DIN 00001835
Director12 Nov 20214 yrs 11 moApollo Hospitals Enterprise Limited
Bhaskar Jyoti Sarma
DIN 05282550
Director11 May 20233 yrs 5 moAssam Hospitals Limited
Akiduz Zaman
DIN 00941647
Director16 May 20233 yrs 5 moAssam Hospitals Limited

People of Apollo Hospitals

106 people are tracked at Apollo Hospitals (48 in leadership, 8 in board & advisors, 50 in team); the tracked headcount is 1,426.

NameRoleGroup
Prathap C Reddy
Founder & ChairmanLeadership
Shivakumar Pattabhiraman
Co-CEOLeadership
Tejesvi Veerepalli
Co-CEOLeadership
Madhu Sasidhar
Co-CEOLeadership
Vikram Thaploo
Co-CEOLeadership
Punyabrata Mukherjee
Medical DirectorLeadership
Sangita Reddy
Joint Managing DirectorLeadership
Suneeta Reddy
Managing DirectorLeadership
Rahul R Menon
Chief Operating Officer & Director Medical Services, Cluster 2Leadership
Arnab S Raha
Unit Head-apollo Hospital & Apollo Cancer Centres, BilaspurLeadership
Dr Anika Singhal
Lab HeadLeadership
Umashankar Rajagopal
Deputy General ManagerLeadership
Krishna Murthy V
Dy General ManagerLeadership
Dr.visweswararao Brungi
Reagional Medical Services Head Ap &ts Apollo HospitsLeadership
Dr Narendra Patil
Deputy General Manager - Medical ServicesLeadership
Dr. Siva Prasad Rao B
Unit Head And Medical HeadLeadership
Anubhav Saha
Deputy General Manager - New Initiatves, EA To MDLeadership
Priya Paleja
Deputy General ManagerLeadership
Dr. Amba Shree Bhardwaj
Cluster Head - Multi LocationsLeadership
Dr Rukmini D N
Deputy General Manager OperationsLeadership

86 more people are available in the full profile.

Premium access

Complete people profiles for Apollo Hospitals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Apollo Hospitals

Apollo Hospitals is a publicly listed company on the NSE with ticker symbol APOLLOHOSP in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date10 Jan 1996
  • Listed onNSE: APOLLOHOSP
  • Listed entityApollo Hospitals Enterprise Limited
  • Exchange sectorHealth services
  • ISININE437A01024
  • Share price₹7,824.00 (-0.6% on the day) · 2026-10-14
  • Market capitalisation₹113,202 Cr
  • Price to earnings53.9
  • EPS (diluted, trailing year)₹145.25
  • Dividend yield0.25%
  • Volume (last session)546,845

Financials of Apollo Hospitals

Exchange-reported figures of Apollo Hospitals Enterprise Limited, the listed company behind Apollo Hospitals (NSE: APOLLOHOSP).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹25,228 Cr
+15.8% YoY
EBITDA
₹3,750 Cr
+24.1% YoY
Profit After Tax
₹1,869 Cr
+37.8% YoY
Net Worth
₹9,485 Cr
-11.0% YoY
Total Assets
₹18,610 Cr
+11.7% YoY
Total Debt
₹8,488 Cr
+56.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue25,22821,79419,05916,61214,66310,56011,247
Revenue growth+15.8%+14.4%+14.7%+13.3%+38.9%-6.1%-
EBITDA3,7503,0222,3912,0502,1851,1371,587
EBITDA margin+14.9%+13.9%+12.5%+12.3%+14.9%+10.8%+14.1%
Profit before tax2,6612,0391,3801,1441,578221660
Net profit1,8691,356874810836110326
Net profit margin+7.4%+6.2%+4.6%+4.9%+5.7%+1.0%+2.9%
EPS (₹)135.03100.5562.4956.9673.4110.4632.68
Balance sheet
Total assets18,61016,65412,75411,55710,6129,5759,450
Net worth9,48510,6626,9356,1975,6234,6023,339
Total debt8,4885,4155,3334,3324,0684,1603,596
Cash & bank1,1171,360934776924724467
Net working capital2,7942,0511,0471,6161,4331,062978
Cash flow
Cash from operations2,8562,1361,9201,3771,6961,2651,293
Cash from investing(2,145)(3,383)(1,537)(857)(747)(880)(289)
Cash from financing(478)1,319(311)(633)(792)(340)(910)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue7,6156,9326,6066,4776,1895,8425,5925,527
Revenue growth (YoY)+23.0%+18.7%+18.1%+17.2%+10.7%+14.9%--
Other income57.8061.3054.0067.7060.8053.8071.6069.10
EBITDA1,1911,0681,011946918852770762
EBITDA margin+15.6%+15.4%+15.3%+14.6%+14.8%+14.6%+13.8%+13.8%
Depreciation230222224219205215211185
Interest11410811911398.60108115110
Profit before tax904799722682675583516536
Tax245188170166181142101157
Net profit660610551516494441414379
EPS (₹)43.7940.3736.7634.9433.2030.1027.1025.89
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue9,3268,2027,2746,5256,0984,6549,794
Revenue growth+13.7%+12.8%+11.5%+7.0%+31.0%-52.5%-
EBITDA2,3172,0441,7981,6821,4137041,415
EBITDA margin+24.8%+24.9%+24.7%+25.8%+23.2%+15.1%+14.5%
Profit before tax1,9461,6881,3291,22894591.00682
Net profit1,4071,2029821,073654110358
Net profit margin+15.1%+14.7%+13.5%+16.4%+10.7%+2.4%+3.7%
EPS (₹)103.8090.1570.2775.4446.267.3033.78
Balance sheet
Total assets13,15611,82610,9399,4558,8698,2588,570
Net worth9,9638,7347,7116,9256,1115,2023,988
Total debt3,1903,0903,2222,5202,7523,0503,160
Cash & bank349594342318557408346
Net working capital4329041,9011,9171,9399081,005
Cash flow
Cash from operations2,0591,7421,1911,2241,2019161,096
Cash from investing(1,413)(1,046)(835)(588)(504)(781)(264)
Cash from financing(537)(739)(297)(779)(577)(176)(771)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2,9032,6562,4382,3642,3562,1682,0752,055
Revenue growth (YoY)+23.2%+22.5%+17.5%+15.0%+10.3%+11.9%--
Other income11147.1090.3010814132.5091.60108
Total expenses2,1802,0001,8431,7821,7631,6221,5541,543
EBITDA723656596582593546521512
EBITDA margin+24.9%+24.7%+24.4%+24.6%+25.2%+25.2%+25.1%+24.9%
Depreciation141134128127122123130108
Interest71.2068.3063.4061.7057.9058.8063.1062.00
Profit before tax622501494502554397420449
Tax14611611211813489.7086.60108

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue7,6156,9326,6066,4776,1895,8425,5925,527
Revenue growth (YoY)+23.0%+18.7%+18.1%+17.2%+10.7%+14.9%--
Other income57.8061.3054.0067.7060.8053.8071.6069.10
EBITDA1,1911,0681,011946918852770762
EBITDA margin+15.6%+15.4%+15.3%+14.6%+14.8%+14.6%+13.8%+13.8%
Depreciation230222224219205215211185
Interest11410811911398.60108115110
Profit before tax904799722682675583516536
Tax245188170166181142101157
Net profit660610551516494441414379
EPS (₹)43.7940.3736.7634.9433.2030.1027.1025.89
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue25,22821,79419,05916,61214,66310,56011,247
Revenue growth+15.8%+14.4%+14.7%+13.3%+38.9%-6.1%-
Other income23623312690.30372106225
Total expenses21,47818,77216,66814,56312,4789,4239,660
Employee cost3,0002,7692,4942,1771,7861,6011,853
EBITDA3,7503,0222,3912,0502,1851,1371,587
EBITDA margin+14.9%+13.9%+12.5%+12.3%+14.9%+10.8%+14.1%
Depreciation876758687615601573620
Interest450458449381379449533
Profit before tax2,6612,0391,3801,1441,578221660
Tax65853444625647784.70225
Net profit1,8691,356874810836110326
Net profit margin+7.4%+6.2%+4.6%+4.9%+5.7%+1.0%+2.9%
EPS (₹)135.03100.5562.4956.9673.4110.4632.68
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital76.902,52271.9071.9071.9071.9069.60
Reserves & surplus9,4088,1406,8646,1265,5514,5313,270
Shareholders' funds (net worth)9,48510,6626,9356,1975,6234,6023,339
Minority interest494441385334280200131
Secured loans3,1862,8133,1462,5812,6072,8383,163
Unsecured loans5,3022,6012,1861,7511,4611,321433
Total debt8,4885,4155,3334,3324,0684,1603,596
Total liabilities18,61016,65412,75411,55710,6129,5759,450
Assets
Gross block18,25116,19014,20212,48211,7269,62110,231
Net block12,27210,9889,6648,5208,2966,7787,432
Capital work in progress1,03292187361045.50234236
Investments2,1792,4879865748161,343434
Inventories542481460390432250738
Sundry debtors3,4853,0162,5152,2341,7651,3311,027
Cash & bank balances1,1171,360934776924724467
Loans & advances739740687645439338340
Total current assets5,8835,5974,5964,0453,5592,6442,572
Total current liabilities3,0893,5463,5492,4282,1271,5821,594
Net working capital2,7942,0511,0471,6161,4331,062978
Total assets18,61016,65412,75411,55710,6129,5759,450
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash578506433546389381286
Net cash from operating activities2,8562,1361,9201,3771,6961,2651,293
Net cash from investing activities(2,145)(3,383)(1,537)(857)(747)(880)(289)
Net cash from financing activities(478)1,319(311)(633)(792)(340)(910)
Net change in cash23372.6072.10(113)15844.5094.50
Closing cash1,1171,360934776924724467
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+15.8%+14.4%+14.7%+13.3%+38.9%-6.1%-
EBITDA growth+24.1%+26.4%+16.6%-6.2%+92.1%-28.3%-
PBT growth+30.5%+47.7%+20.7%-27.5%+615.0%-66.6%+77.1%
Net income growth+37.8%+55.1%+7.9%-3.0%+658.9%-66.3%-
Revenue CAGR (3Y)+14.9%+14.1%+21.8%+13.9%+15.1%+8.6%+15.7%
EBITDA CAGR (3Y)+22.3%+11.4%+28.1%+8.9%+27.1%+12.8%+29.6%
Profitability & leverage
Net income margin+7.9%+6.9%+4.9%+5.3%+7.5%+1.3%+3.9%
Return on capital employed+18.1%+17.5%+15.5%+14.2%+16.7%+6.5%+11.9%
Return on net worth+22.6%+19.9%+14.3%+15.0%+17.3%+2.4%+9.2%
Debt / equity0.690.610.740.710.810.981.09
Long-term debt / equity0.470.490.580.610.730.830.87
Interest cover15.6420.2526.3826.5523.9079.6055.07
Efficiency & per share
Fixed asset turnover1.471.431.431.371.371.061.34
Inventory turnover49.3146.3444.8540.4243.0421.3917.01
Debtors turnover7.767.888.038.319.478.9610.97
EPS (₹)135.03100.5562.4956.9673.4110.4632.68
Dividend per share (₹)20.0012.6616.0015.0011.753.006.00
Book value per share (₹)659.26571.09481.75430.43390.51319.52239.32
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2,9032,6562,4382,3642,3562,1682,0752,055
Revenue growth (YoY)+23.2%+22.5%+17.5%+15.0%+10.3%+11.9%--
Other income11147.1090.3010814132.5091.60108
Total expenses2,1802,0001,8431,7821,7631,6221,5541,543
EBITDA723656596582593546521512
EBITDA margin+24.9%+24.7%+24.4%+24.6%+25.2%+25.2%+25.1%+24.9%
Depreciation141134128127122123130108
Interest71.2068.3063.4061.7057.9058.8063.1062.00
Profit before tax622501494502554397420449
Tax14611611211813489.7086.60108
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue9,3268,2027,2746,5256,0984,6549,794
Revenue growth+13.7%+12.8%+11.5%+7.0%+31.0%-52.5%-
Other income372348180152140148175
Total expenses7,0106,1585,4764,8434,6863,9508,379
Employee cost1,6861,5971,4251,2721,1501,2181,519
EBITDA2,3172,0441,7981,6821,4137041,415
EBITDA margin+24.8%+24.9%+24.7%+25.8%+23.2%+15.1%+14.5%
Depreciation500449399367363421482
Interest242254250239244340426
Profit before tax1,9461,6881,3291,22894591.00682
Tax454392318143280(14.00)212
Net profit1,4071,2029821,073654110358
Net profit margin+15.1%+14.7%+13.5%+16.4%+10.7%+2.4%+3.7%
EPS (₹)103.8090.1570.2775.4446.267.3033.78
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital71.9071.9071.9071.9071.9071.9069.60
Reserves & surplus9,8918,6627,6396,8536,0395,1303,919
Shareholders' funds (net worth)9,9638,7347,7116,9256,1115,2023,988
Secured loans1,8221,7831,9561,6562,0242,2812,852
Unsecured loans1,3671,3061,266865728768308
Total debt3,1903,0903,2222,5202,7523,0503,160
Total liabilities13,15611,82610,9399,4558,8698,2588,570
Assets
Gross block10,6779,6608,9367,6397,3887,0258,146
Net block6,9166,3486,0325,0785,1215,0386,056
Capital work in progress32030620096.4023.90219227
Investments4,8933,9112,6212,2172,0592,0911,076
Inventories14712711998.30147210707
Sundry debtors8478158088208241,204966
Cash & bank balances349594342318557408346
Loans & advances4925511,7221,6231,426259268
Total current assets1,8352,0872,9922,8592,9542,0822,288
Total current liabilities1,4031,1831,0909421,0161,1731,283
Net working capital4329041,9011,9171,9399081,005
Total assets13,15611,82610,9399,4558,8698,2588,570
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash233276217360239280219
Net cash from operating activities2,0591,7421,1911,2241,2019161,096
Net cash from investing activities(1,413)(1,046)(835)(588)(504)(781)(264)
Net cash from financing activities(537)(739)(297)(779)(577)(176)(771)
Net change in cash109(42.90)59.10(143)120(41.20)61.50
Closing cash349594342318557408346
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+13.7%+12.8%+11.5%+7.0%+31.0%-52.5%-
EBITDA growth+13.3%+13.7%+6.9%+19.0%+100.7%-50.3%-
PBT growth+15.3%+27.1%+8.2%+29.9%+938.5%-86.7%+47.5%
Net income growth+17.0%+22.4%-8.4%+64.0%+495.6%-69.4%-
Revenue CAGR (3Y)+12.7%+10.4%+16.1%-12.7%-9.9%-13.5%+15.8%
EBITDA CAGR (3Y)+11.3%+13.1%+36.7%+5.9%+11.5%-5.3%+22.3%
Profitability & leverage
Net income margin+16.0%+15.8%+13.9%+16.6%+10.9%+2.3%+4.8%
Return on capital employed+17.5%+17.1%+15.5%+16.0%+12.6%+3.6%+12.1%
Return on net worth+16.0%+15.8%+13.8%+16.6%+11.6%+2.4%+9.1%
Debt / equity0.340.380.390.400.510.680.81
Long-term debt / equity0.310.350.350.370.470.570.65
Interest cover13.3115.9317.8618.1623.25120.3145.65
Efficiency & per share
Fixed asset turnover0.920.880.880.870.850.611.47
Inventory turnover68.2266.8767.0453.2434.1510.1415.44
Debtors turnover11.2210.118.937.946.014.2910.45
EPS (₹)103.8090.1570.2775.4446.267.3033.78
Dividend per share (₹)20.0012.6616.0015.0011.753.006.00
Book value per share (₹)692.85607.39536.22481.56424.94361.72286.52

Investments & Acquisitions by Apollo Hospitals

Apollo Hospitals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include AyurVAID Hospitals, Hetero Pharmacy and Nova Specialty Hospitals.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Onco
Comprehensive cancer care navigation and support services are provided.
onco.comBengaluru, India2016Jul 2025••••
AyurVAID Hospitals
A chain of Ayurveda hospitals is operated in India.
ayurvaid.comBengaluru, India2005Oct 2022$3.21M
Nova Specialty Hospitals
Chain of ambulatory surgery centres
novaspecialtyhospitals.comBengaluru, India2009Jan 2015$21.24M
Hetero Pharmacy
A chain of pharmacy stores is operated in India.
heteropharmacy.comHyderabad, India1993Sep 2014$23.97M
Premium access

Complete acquisition details for Apollo Hospitals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Apollo Hospitals

8 dated milestones of Apollo Hospitals across 42 years, from founding to its latest funding, stage changes and deals.

  1. Founded Apollo Hospitals is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $7.5M.
  4. Acquisition Acquires Hetero Pharmacy.
  5. Acquisition Acquires Nova Specialty Hospitals.
  6. Funding Latest funding round, Post-IPO, of $160.0M.
  7. Acquisition Acquires AyurVAID Hospitals.
  8. Acquisition Acquires Onco.

Competitors of Apollo Hospitals

Apollo Hospitals has 3 listed competitors in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Fortis Healthcare
fortishealthcare.com1996Gurugram, India1,565
Multi-specialty hospital services are provided across India by Fortis Healthcare.
Ujala Cygnus
ujalacygnus.com2011Delhi, India$36.74M2,084
A chain of multi-specialty hospitals is operated in India.
Narayana Health
narayanahealth.org2000Bengaluru, India$148.2M8,145
A chain of multi-specialty hospitals is operated in India.
Premium access

Detailed competitors of Apollo Hospitals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Apollo Hospitals

The website of Apollo Hospitals (apollohospitals.com) receives about 5.5M visits a month and ranks #11,914 among all websites worldwide, #227 in Medicine.

  • Monthly visits
    5.5M

    ▲ 0.9% vs previous month

  • Unique visitors
    3.1M

    per month

  • Global rank
    #11,914

    among all websites

  • Category rank
    #227

    Health · Medicine

Similar websites

Websites whose visitors overlap most with Apollo Hospitals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Fortis Healthcare
fortishealthcare.com
100%
808.8K#56,407View details
Max Healthcare
maxhealthcare.in
92%
1.5M#37,801View details
Mayo Clinic
mayoclinic.org
81%
62.3M#1,090View details
Hospitalkhoj
hospitalkhoj.com
76%
View details
Johns Hopkins Medicine
hopkinsmedicine.org
75%
10M#6,665View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Apollo Hospitals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as Apollo Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloudnine
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
HCG
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M321
Medanta
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Apollo Hospitals

Apollo Hospitals: CLSA on Apollo Hospitals maintains Outperform, Target Price Rs 9860; Q2 revenue grew 23% YoY, with healthy growth across segments and a 70bps improvement in margins. Capacity additions of 4718 census beds by FY31 remain on track, with 520 beds already commissioned. Healthcare margins are expected to improve from 24%, supported by established hospitals and breakeven at newer units.
Exchange Update • 2 days ago
Apollo Hospitals: JPMorgan on Apollo Hospitals maintains Overweight, Target Price Rs 10700; Q2 revenue and EBITDA grew 23% and 29% YoY, respectively, with revenue 2% ahead of consensus. Hospital demand remained strong, with occupancy rising 400bps to 73%, inpatient volumes growing 14% and ARPP increasing 8%. New-unit losses and pre-operative costs weighed on margins. HealthCo's demerger remains on track for Q4FY27, while digital health achieved cash breakeven.
Exchange Update • 2 days ago
Apollo Hospitals: Co' Apollo HealthCo Lowers Q4 FY27 Margin Expectation To About 6% Due To One-Time Costs, But Anticipates Higher Single-Digit Margins In Three To Four Years.
Exchange Update • 2 days ago
Apollo Hospitals: Citi on Apollo Hospitals maintains Buy, Target Price Rs 10770; Q2 consolidated revenue, EBITDA and PAT grew 23%, 29% and 32% YoY, respectively. Hospitals revenue increased 23%, driven by 14% inpatient volume growth and an 8% rise in ARPP, while HealthCo EBITDA grew 75% and its digital business turned cash-positive for the first time. Strong hospital demand, improving HealthCo profitability and the bed-expansion pipeline support the outlook, while oncology trade-margin caps and regulatory notices remain key areas to monitor.
Exchange Update • 3 days ago
Apollo Hospitals: Sees Opportunities For Larger Profit Margins In Hospital Operations
Exchange Update • 3 days ago
APOLLOHOSP: Q2 REVENUE 76.15B RUPEES VS 62B (YOY)
Exchange Update • 4 days ago
APOLLOHOSP: Q2 CONS NET PROFIT 6.3B RUPEES VS 4.77B (YOY); EST 6.3B
Exchange Update • 4 days ago
APOLLOHOSP: Q2 EBITDA 11.9B RUPEES VS 9.4B (YOY); Q2 EBITDA MARGIN 15.64% VS 14.93% (YOY)
Exchange Update • 4 days ago
Kerala Government Plans New Bill To Control Private Hospital Fees, Says Health Minister.
Exchange Update • 13 days ago
APOLLOHOSP: RS. 54.48 CRORES BSE BLOCK TRADE; FOR ~ 69,400 SHARES, AT RS. 7850.00
Exchange Update • 1 month ago
Premium access

Complete news archive for Apollo Hospitals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Articles about Apollo Hospitals on our blog

Frequently Asked Questions about Apollo Hospitals

Apollo Hospitals was founded in 1983 and raised its 1st funding round 22 years after it was founded.

Apollo Hospitals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Shivakumar Pattabhiraman is the CEO of Apollo Hospitals, as recorded in our data.

Apollo Hospitals has 1,426 employees.

The primary company behind Apollo Hospitals, Apollo Hospitals Enterprise Limited, reported revenue of ₹25,465 Cr for FY 2026, up 16% year on year.

Apollo Hospitals was founded in 1983 in Chennai, India, within the healthcare sector. A network of multispecialty hospitals is managed across the country, where services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, transplants, nephrology, urology, pulmonology, endocrinology, rheumatology, dermatology, and pediatrics are provided. Emphasis is placed on disease prevention and healthy lifestyles through educational programs and community efforts.

Apollo Hospitals's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Apollo Hospitals offers Cardiac Sciences, Oncology Services, and Neurosciences.

Yes, Apollo Hospitals is publicly traded on NSE under the ticker symbol APOLLOHOSP.

Apollo Hospitals has made 4 acquisitions, including AyurVAID Hospitals, Hetero Pharmacy, and Nova Specialty Hospitals.

Apollo Hospitals has 5 investors. Key investors include KKR, Sanofi, One Equity Partners, Apax Partners, and IFC Asset Management Company.

Apollo Hospitals is associated with 6 legal entities: Apollo Hospitals Enterprise Limited, Neocardio Diagnostics Llp, Assam Hospitals Limited and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available